Guillaume Jean

Summary

Country: France

Publications

  1. doi request reprint [Bone biomarkers in haemodialysis patients: bone alkaline phosphatase or ß-Crosslaps?]
    Guillaume Jean
    NEPHROCARE Tassin Charcot, 7, avenue du Maréchal Foch, 69110 Sainte Foy Les Lyon, France
    Nephrol Ther 9:154-9. 2013
  2. doi request reprint [Higher dialysate calcium is not associated with mortality in hemodialysis patients: results from the French ARNOS study]
    Guillaume Jean
    NEPHROCARE Tassin Charcot, 7, avenue du Maréchal Foch, 69110 Sainte Foy Les Lyon, France
    Nephrol Ther 9:103-7. 2013
  3. doi request reprint Biological impact of targeted dialysate calcium changes in haemodialysis patients: the key role of parathyroid hormone
    Guillaume Jean
    NEPHROCARE Tassin Charcot, Sainte Foy Les Lyon, France
    Nephrol Dial Transplant 28:176-82. 2013
  4. doi request reprint [How to deal with those low parathyroid hormone values in dialysis patients?]
    Guillaume Jean
    NEPHROCARE Tassin Charcot, 7, avenue Maréchal Foch, 69110 Sainte Foy Les Lyon, France
    Nephrol Ther 8:462-7. 2012
  5. doi request reprint Increased levels of serum parathyroid hormone and fibroblast growth factor-23 are the main factors associated with the progression of vascular calcification in long-hour hemodialysis patients
    Guillaume Jean
    NEPHROCARE Tassin Charcot, Sainte Foy Les Lyon, France
    Nephron Clin Pract 120:c132-8. 2012
  6. doi request reprint [Questions about the ADVANCE study]
    Guillaume Jean
    Centre de Rein Artificiel, NephroCare, Tassin La Demi Lune, France
    Nephrol Ther 8:131-4. 2012
  7. doi request reprint Total and bone-specific alkaline phosphatases in haemodialysis patients with chronic liver disease
    Guillaume Jean
    NEPHROCARE Tassin Charcot, Sainte Foy Les Lyon, France
    Clin Biochem 45:436-9. 2012
  8. doi request reprint [Clinical and biological forms of secondary hyperparathyroidism in dialysis patients]
    Guillaume Jean
    Centre de Rein Artificiel, NephroCare, 42, avenue du 8 Mai 1945, 69160 Tassin La Demi Lune, France
    Nephrol Ther 8:35-40. 2012
  9. doi request reprint [An efficient strategy to decrease the central venous catheter-related adverse events rate in haemodialysis patients]
    Guillaume Jean
    Centre de Rein Artificiel, 42, avenue du 8 Mai 1945, 69160 Tassin La Demi Lune, France
    Nephrol Ther 5:280-6. 2009
  10. doi request reprint High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients
    Guillaume Jean
    Centre de Rein Artificiel, Tassin La Demi Lune, France
    Nephrol Dial Transplant 24:2792-6. 2009

Detail Information

Publications52

  1. doi request reprint [Bone biomarkers in haemodialysis patients: bone alkaline phosphatase or ß-Crosslaps?]
    Guillaume Jean
    NEPHROCARE Tassin Charcot, 7, avenue du Maréchal Foch, 69110 Sainte Foy Les Lyon, France
    Nephrol Ther 9:154-9. 2013
    ..We compared b-ALP, t-ALP, and CTX levels in patients on haemodialysis (HD)...
  2. doi request reprint [Higher dialysate calcium is not associated with mortality in hemodialysis patients: results from the French ARNOS study]
    Guillaume Jean
    NEPHROCARE Tassin Charcot, 7, avenue du Maréchal Foch, 69110 Sainte Foy Les Lyon, France
    Nephrol Ther 9:103-7. 2013
    ..Prescribing DCa on an individual basis according to various mineral metabolism parameters and treatments appears to be safe irrespective of the DCa dosage...
  3. doi request reprint Biological impact of targeted dialysate calcium changes in haemodialysis patients: the key role of parathyroid hormone
    Guillaume Jean
    NEPHROCARE Tassin Charcot, Sainte Foy Les Lyon, France
    Nephrol Dial Transplant 28:176-82. 2013
    ..5 mmol/L in European countries. The aim of the study was to assess the short-term biological impact of individual DCa prescription aiming at maintaining normal serum calcium and serum parathyroid hormone (PTH) between 150 and 300 pg/mL...
  4. doi request reprint [How to deal with those low parathyroid hormone values in dialysis patients?]
    Guillaume Jean
    NEPHROCARE Tassin Charcot, 7, avenue Maréchal Foch, 69110 Sainte Foy Les Lyon, France
    Nephrol Ther 8:462-7. 2012
    ..Based on biological and clinical data, we aimed at identifying the different types of low PTH (L-PTH) in order to determine the best therapeutic strategies in these patients...
  5. doi request reprint Increased levels of serum parathyroid hormone and fibroblast growth factor-23 are the main factors associated with the progression of vascular calcification in long-hour hemodialysis patients
    Guillaume Jean
    NEPHROCARE Tassin Charcot, Sainte Foy Les Lyon, France
    Nephron Clin Pract 120:c132-8. 2012
    ..It remains to be seen whether patients should be treated to lower their PTH value, even within the target range, using calcitriol analogs, calcimimetics, parathyroidectomy, or by modifying the Klotho-FGF-23 axis...
  6. doi request reprint [Questions about the ADVANCE study]
    Guillaume Jean
    Centre de Rein Artificiel, NephroCare, Tassin La Demi Lune, France
    Nephrol Ther 8:131-4. 2012
    ..Therefore, the nephrologist community should conduct relevant independent studies in order to improve the diagnosis and treatment of SHPT...
  7. doi request reprint Total and bone-specific alkaline phosphatases in haemodialysis patients with chronic liver disease
    Guillaume Jean
    NEPHROCARE Tassin Charcot, Sainte Foy Les Lyon, France
    Clin Biochem 45:436-9. 2012
    ....
  8. doi request reprint [Clinical and biological forms of secondary hyperparathyroidism in dialysis patients]
    Guillaume Jean
    Centre de Rein Artificiel, NephroCare, 42, avenue du 8 Mai 1945, 69160 Tassin La Demi Lune, France
    Nephrol Ther 8:35-40. 2012
    ..In our study, HPT cases did not show uniform findings in Hémodialyse (HD) patients because of the variation in the stages of the disease at the time of diagnosis...
  9. doi request reprint [An efficient strategy to decrease the central venous catheter-related adverse events rate in haemodialysis patients]
    Guillaume Jean
    Centre de Rein Artificiel, 42, avenue du 8 Mai 1945, 69160 Tassin La Demi Lune, France
    Nephrol Ther 5:280-6. 2009
    ..Catheter-related adverse events (CAE) remain a major cause of mortality and morbidity...
  10. doi request reprint High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients
    Guillaume Jean
    Centre de Rein Artificiel, Tassin La Demi Lune, France
    Nephrol Dial Transplant 24:2792-6. 2009
    ....
  11. doi request reprint [The French clinician's guide to the Kidney disease: Improving global outcomes (KDIGO) for chronic kidney disease-mineral and bone disorders (CKD-MBD)]
    G Jean
    Centre de Rein Artificiel, 69160 Tassin La Demi Lune, France
    Nephrol Ther 6:151-7. 2010
    ..A majority of these recommendations are not based on evidence and their feasibility and relevance need to be assessed...
  12. doi request reprint Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation
    Guillaume Jean
    Centre de Rein Artificiel, 42 Avenue du 8 Mai 1945, 69160, Tassin Demi lune, France
    Nephrol Dial Transplant 24:3799-805. 2009
    ..Objective. The aim was to assess the long-term efficiency and safety of a monthly oral dose of cholecalciferol (100 000 IU) in vitamin D-deficient haemodialysis (HD) patients...
  13. doi request reprint [Guidelines for vitamin D prescription in dialysis patients]
    Guillaume Jean
    Centre de Rein Artificiel, néphrologie et dialyse, 69160 Tassin La Demi Lune, France
    Nephrol Ther 5:520-32. 2009
    ....
  14. doi request reprint Treating mineral metabolism disorders in patients undergoing long hemodialysis: a search for an optimal strategy
    Guillaume Jean
    Centre de Rein Artificiel, 69160 Tassin La Demi Lune, France
    Hemodial Int 13:526-32. 2009
    ....
  15. doi request reprint [Treatment of secondary hyperparathyroidism resistant to conventional therapy and tertiary hyperparathyroidism with Cinacalcet: an efficiency strategy]
    Guillaume Jean
    Centre de Rein Artificiel, 42, avenue du 8 Mai 1945, 69160 Tassin La Demi Lune, France
    Nephrol Ther 6:105-10. 2010
    ..The aim of our study is to prospectively assess the tolerance and efficacy of CC in patients, treated in one centre using long haemodialysis, with SHPT who do not respond to conventional therapy...
  16. doi request reprint [Calciphylaxis in dialysis patients: To recognize and treat it as soon as possible]
    Guillaume Jean
    Centre de Rein Artificiel, 42, avenue du 8 Mai 1945, 69160 Tassin La Demi Lune, France
    Nephrol Ther 6:499-504. 2010
    ..Prevention includes identification of at-risk patients in order to optimize the treatment of the identified risk factors for CPX...
  17. doi request reprint Prevention of secondary hyperparathyroidism in hemodialysis patients: the key role of native vitamin D supplementation
    G Jean
    Centre de Rein Artificiel, Tassin La Demi Lune, France
    Hemodial Int 14:486-91. 2010
    ..0001). Since 2004, SHPT has decreased drastically in incident and prevalent HD patients. The preventive role of N-VitD supplementation appears to be obvious and represents one more argument for its general recommendation in CKD patients...
  18. doi request reprint Impact of hypovitaminosis D and alfacalcidol therapy on survival of hemodialysis patients: results from the French ARNOS study
    G Jean
    Centre de Rein Artificiel, Service d Hemodialyse, Tassin La Demi Lune, France
    Nephron Clin Pract 118:c204-10. 2011
    ..The aim of this study was to determine the relationship between serum 25-hydroxyvitamin D (25-OHD) levels and alfacalcidol therapy with HD patients' outcomes...
  19. doi request reprint Association between very low PTH levels and poor survival rates in haemodialysis patients: results from the French ARNOS cohort
    G Jean
    Centre de Rein Artificiel, Service d Hemodialyse, Tassin La Demi Lune, France
    Nephron Clin Pract 118:c211-6. 2011
    ..The aim of the study was to assess the frequency, the associated factors, and the prognosis of non-surgical VLPL in a cohort of prevalent HD patients...
  20. doi request reprint [How to manage mineral metabolism disorders in renal failure]
    Guillaume Jean
    Centre de Rein Artificiel, 42, avenue du 8 Mai 1945, 69160 Tassin La Demi Lune, France
    Presse Med 40:1043-52. 2011
    ..Managing these therapies adequately can help maintain the main biological values (i.e. serum PTH, calcium, phosphorus, and ALP) within their recommended ranges...
  21. doi request reprint Calcium carbonate, but not sevelamer, is associated with better outcomes in hemodialysis patients: results from the French ARNOS study
    Guillaume Jean
    Centre de Rein Artificiel, Service d Hemodialyse, Tassin, France
    Hemodial Int 15:485-92. 2011
    ..This novel result can be partly accounted for by the differences in mineral metabolism disorder management that exist between randomized controlled trials and "real life" conditions...
  22. doi request reprint Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences
    Guillaume Jean
    Centre de Rein Artificiel, Tassin La Demi Lune, Tassin La Demi Lune, France
    Nephrol Dial Transplant 24:948-55. 2009
    ....
  23. doi request reprint Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment
    G Jean
    Centre de Rein Artificiel, Tassin, France
    Nephron Clin Pract 110:c58-65. 2008
    ..End-stage renal disease (ESRD) patients are thought to have impaired 1-alpha-hydroxylase capacity, but an extrarenal source of 1,25(OH)(2)D has been recognized...
  24. doi request reprint Vitamin D deficiency and associated factors in hemodialysis patients
    Guillaume Jean
    Centre de Rein Artificiel, Tassin La Demi Lune, France
    J Ren Nutr 18:395-9. 2008
    ..Only limited data and no guidelines are available on vitamin D deficiency in hemodialysis patients...
  25. doi request reprint Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers
    Guillaume Jean
    Centre de Rein Artificiel, 42 Avenue du 8 Mai 1945, 69160, Tassin La Demi Lune, France
    Nephrol Dial Transplant 23:3670-6. 2008
    ..We aimed to assess the effects of daily 25(OH)D(3) supplementation on mineral metabolism, bone markers and Kidney Disease Outcomes Quality Initiative (KDOQI) targets in haemodialysis (HD) patients for a period of 6 months...
  26. doi request reprint Predialysis systolic blood pressure evolution in incident hemodialysis patients: effects of the dry weight method and prognostic value
    Charles Chazot
    NEPHROCARE Tassin Charcot, Sainte Foy Les Lyon, France
    Blood Purif 33:275-83. 2012
    ..We report the evolution of predialysis BP in incident patients treated with the dry weight method and its relationship with patients' outcomes...
  27. doi request reprint Fluid overload correction and cardiac history influence brain natriuretic peptide evolution in incident haemodialysis patients
    Charles Chazot
    NephroCare, Tassin, France
    Nephrol Dial Transplant 26:2630-4. 2011
    ..We report in this study the evolution of BNP levels in incident HD patients, its relationship with fluid removal and cardiac history as well as its prognostic value...
  28. doi request reprint The plasma level of brain natriuretic peptide is increased in malnourished hemodialysis patients
    Charles Chazot
    Centre de Rein Artificiel, Tassin, France
    Blood Purif 28:187-92. 2009
    ..In a cross-sectional study, we assessed the relationship between predialysis plasma BNP level and nutritional markers in chronic HD patients...
  29. ncbi request reprint Long 3 x 8 hr dialysis: a three-decade summary
    Bernard Charra
    Centre de Rein Artificiel de Tassin, Tassin, France
    J Nephrol 16:S64-9. 2003
    ..Due to the change in case mix a decreasing number of patients are able or willing to go on overnight dialysis, education to be autonomous is more difficult, but the benefit is still there...
  30. ncbi request reprint Stability of nutritional parameters during a 5-year follow-up in patients treated with sequential long-hour hemodialysis
    Charles Chazot
    Centre de Rein Artificiel, Tassin, France
    Hemodial Int 10:389-93. 2006
    ..The role of a large dialysis dose in maintaining nutritional status in HD patients is discussed...
  31. doi request reprint Treatment time
    Charles Chazot
    Centre de Rein Artificiel, Tassin, France
    Contrib Nephrol 161:154-61. 2008
    ..All these clinical markers that represent the essence of dialysis adequacy, favor strongly the strategy of a sequential long-hour dialysis program that may clinically and economically challenge with daily programs...
  32. doi request reprint Intradialytic hypertension: it is time to act
    Charles Chazot
    NephroCare, Tassin, France
    Nephron Clin Pract 115:c182-8. 2010
    ..Fluid removal remains the key point for treating IDH. Several important unanswered questions remain and the need for further research is highlighted...
  33. doi request reprint The advantages and challenges of increasing the duration and frequency of maintenance dialysis sessions
    Charles Chazot
    Centre de Rein Artificiel, Tassin, France
    Nat Clin Pract Nephrol 5:34-44. 2009
    ..This Review outlines the advantages of longer and/or more frequent dialysis sessions and highlights the barriers to adoption of such regimens, which largely relate to economics, patient willingness, and organization of dialysis units...
  34. doi request reprint Thrice-weekly nocturnal hemodialysis: the overlooked alternative to improve patient outcomes
    Charles Chazot
    Department of Nephrology, NEPHROCARE Tassin Charcot, Sainte Foy Les Lyon, Rhone Alpes, France
    Nephrol Dial Transplant 28:2447-55. 2013
    ..Even if the methodology of the latter studies may not be optimal, we underscore the point that this alternative dialysis prescription should be included in the current debate of novel dialysis strategies...
  35. doi request reprint The dynamics of prognostic indicators: toward earlier identification of dialysis patients with a high risk of dying
    Charles Chazot
    NEPHROCARE Tassin Charcot, Sainte Foy Les Lyon, France
    Kidney Int 84:19-21. 2013
    ....
  36. ncbi request reprint Hemodialysis trends in time, 1989 to 1998, independent of dose and outcome
    B Charra
    Centre de Rein Artificiel, Tassin, France
    Am J Kidney Dis 32:S63-70. 1998
    ..Shortening the HD session leads to impaired control of BP and increasing cardiovascular morbidity (by far the first cause of mortality on HD). In the future, the length of dialysis session should be governed by the demand of BP control...
  37. ncbi request reprint Nutritional effects of carnitine supplementation in hemodialysis patients
    C Chazot
    Centre de Rein Artificiel, Tassin, France
    Clin Nephrol 59:24-30. 2003
    ..As it plays a role in energy utilization and because malnutrition is a frequent complication of HD treatment, we studied the effects of carnitine supplementation on several nutritional parameters in HD patients...
  38. ncbi request reprint Long, slow dialysis
    B Charra
    Centre de Rein Artificiel, Tassin, France
    Miner Electrolyte Metab 25:391-6. 1999
    ..This low salt diet has paradoxically been forgotten in recent years while shortened dialysis time renders it more necessary than ever...
  39. ncbi request reprint Long thrice weekly hemodialysis: the Tassin experience
    B Charra
    Centre de Rein Artificiel de Tassin, Tassin, France
    Int J Artif Organs 27:265-83. 2004
  40. doi request reprint Randomized equivalence study evaluating the possibility of switching hemodialysis patients receiving subcutaneous human erythropoietin directly to intravenous darbepoetin alfa
    Charles Chazot
    Centre de Dialyse, Tassin La Demi Lune, France
    Ann Pharmacother 43:228-34. 2009
    ....
  41. ncbi request reprint Long-term outcome of permanent hemodialysis catheters: a controlled study
    G Jean
    Centre de Rein Artificiel, Tassin La Demi Lune, France
    Blood Purif 19:401-7. 2001
    ..We prospectively compared the long-term outcome of the two most popular devices, Permcath cuffed double catheter and TwinCath uncuffed twin catheter, both inserted percutaneously...
  42. ncbi request reprint Diabetes mellitus in Tassin, France: remarkable transformation in incidence and outcome of ESRD in diabetes
    B Charra
    Centre de Rein Artificiel, Tassin, France
    Adv Ren Replace Ther 8:42-56. 2001
    ..Altogether, the eruption of DM in our unit over the last decade has drastically increased the crude mortality, but the standardized mortality ratio using the USRDS mortality table remained unchanged, about 45 of expected mortality...
  43. ncbi request reprint Malnutrition in long-term haemodialysis survivors
    C Chazot
    Centre de Rein Artificiel, Tassin, France
    Nephrol Dial Transplant 16:61-9. 2001
    ..Among the potential causes leading to malnutrition, inadequate energy intake and micronutrient deficiencies were found in these patients...
  44. ncbi request reprint [Incidence and risk factors for infections from hemodialysis catheters]
    G Jean
    Centre de Rein Artificiel, Tassin La Demi Lune
    Nephrologie 22:443-8. 2001
    ..In spite of recent progress in risk factor understanding, hemodialysis-related infection remains frequent. Multicentre studies are necessary to better evaluated care protocols and new catheter material...
  45. ncbi request reprint [Prevalence of stenosis and thrombosis of central veins in hemodialysis after a tunneled jugular catheter]
    G Jean
    Centre de Rein Artificiel, Tassin La Demi Lune, France
    Nephrologie 22:501-4. 2001
    ..Consequences on peripheral or central vascular access, cost and poor long-term patency rate of angioplasty are of major importance. These results incite us to further reduce the catheter use in dialysis patients...
  46. ncbi request reprint Is post-dialysis urea rebound significant with long slow hemodialysis?
    G Jean
    Centre de Rein Artificiel, Tassin, France
    Blood Purif 16:187-96. 1998
    ..The purpose of the study was to assess the impact of PDUR on the urea reduction ratio (URR), Kt/V and normal protein catabolic rate (nPCR) with long 8-hour slow hemodialysis...
  47. ncbi request reprint Quest for postdialysis urea rebound-equilibrated Kt/V with only intradialytic urea samples
    G Jean
    Centre de Rein Artificiel de Tassin, Tassin La Demi Lune, France
    Kidney Int 56:1149-53. 1999
    ..The aim of our study was to compare these different Kt/V methods during the longer eight-hour hemodialysis sessions, and to determine the optimum intradialytic urea sample time that fits best with PDUR...
  48. ncbi request reprint Biological evolution of renal osteodystrophy after decreasing dialysate calcium from 1.75 to 1.6 mmol/l
    G Jean
    Clin Nephrol 57:91-2. 2002
  49. ncbi request reprint Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias
    G Jean
    Centre du Rein Artificiel de Tassin, 41 Avenue du 8 Mai 1945, F 69160 Tassin la Demi Lune, France
    Nephron 91:399-405. 2002
    ..04). This study confirms the relatively high incidence of bacteremia with tunneled double-lumen silicone catheters and its potential complications. Possible preventive actions are discussed according to the risk factors...
  50. ncbi request reprint Role of sodium in dialysis
    B Charra
    Center of Artificial Kidney, France
    Minerva Urol Nefrol 56:205-13. 2004
    ....
  51. ncbi request reprint 12 months cinacalcet therapy in hemodialysis patients with secondary hyperparathyroidism: effect on bone markers
    G Jean
    Clin Nephrol 68:63-4. 2007
  52. ncbi request reprint Relapsing calciphylaxis in a young obese patient hemo-dialyzed in a 3- x 8-hour schedule with a favorable outcome after switching to a 6- x 4-hour schedule
    G Jean
    Clin Nephrol 70:87-8. 2008